Age (yr; mean ± SEM) |
32.80 ± 2.50 |
53.60 ± 1.40 |
<0.00010 |
Aortic PWV (m/s; mean ± SEM) |
8.48 ± 0.38 |
11.63 ± 0.35 |
<0.00010 |
Smoking (pack-years; median [95% CI]) |
0.00 (0.00 to 5.00) |
5.00 (1.00 to 15.00) |
<0.01000 |
Vintage (mo; mean ± SEM) |
59.00 ± 7.90 |
94.00 ± 9.10 |
0.01000 |
SBP (mmHg; mean ± SEM) |
151.00 ± 6.20 |
158.00 ± 3.10 |
NS |
DBP (mmHg; mean ± SEM) |
86.00 ± 3.80 |
86.00 ± 1.80 |
NS |
Total cholesterol (mmol/L; mean ± SEM) |
4.87 ± 0.30 |
5.18 ± 0.16 |
NS |
Serum albumin (g/L; mean ± SEM) |
40.80 ± 0.40 |
37.90 ± 0.30 |
<0.00010 |
CRP (mg/L) |
2.00 (1.00 to 3.00) |
8.00 (7.00 to 10.00) |
<0.00010 |
Serum Ca (mmol/L; mean ± SEM) |
2.40 ± 0.04 |
2.43 ± 0.02 |
NS |
Ionized Ca (mmol/L; mean ± SEM) |
1.23 ± 0.01 |
1.21 ± 0.01 |
NS |
Serum PO4 (mmol/L; mean ± SEM) |
1.81 ± 0.06 |
2.06 ± 0.06 |
<0.01000 |
Ca*PO4 (mmol2/L2; mean ± SEM) |
4.35 ± 0.17 |
5.00 ± 0.15 |
<0.01000 |
PTH (pg/ml; median [95% CI]) |
411.00 (229.00 to 670.00) |
206.00 (160.00 to 291.00) |
<0.00001 |
Serum Al (μ mol/L; mean ± SEM) |
0.96 ± 0.13 |
1.62 ± 0.14 |
<0.01000 |
Deferoxamine test (ΔAl μ mol/L; mean ± SEM) |
1.48 ± 0.26 |
2.70 ± 0.24 |
<0.01000 |
CaCO3 (g of elemental Ca/d; mean ± SEM) |
1.270 ± 0.300 |
1.900 ± 0.132 |
0.02000 |
1α-OH-D3 (μ g/wk; median [95% CI]) |
0.25 (0.00 to 0.50) |
0.00 (0.00 to 0.25) |
NS |
Resorption surfaces (%; median [95% CI]) |
2.56 (1.71 to 3.85) |
0.68 (0.27 to 1.40) |
<0.00100 |
Osteoclasts/mm2 (median [95% CI]) |
1.70 (1.05 to 2.70) |
0.47 (0.28 to 1.00) |
<0.00100 |
Osteoblastic surfaces (%; median [95% CI]) |
13.00 (10.20 to 15.20) |
3.40 (1.20 to 7.30) |
<0.00100 |
Double tetracycline–labeled surfaces (%; median [95% CI]) |
15.00 (9.00 to 18.50) |
1.30 (0.00 to 3.20) |
<0.00100 |
Al-stained surfaces (%; median [95% CI]) |
0.00 (0.00 to 7.50) |
28.50 (17.00 to 50.30) |
<0.01000 |
Post-PTX hypoparathyroidism (yes/no) (n) |
0/18 |
8/40 |
<0.01000 |